|
[1]
|
Quinn, J.J. and Chang, H.Y. (2016) Unique Features of Long Non-Coding RNA Biogenesis and Function. Nature Re-views Genetics, 17, 47-62. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Qin, T., Li, J. and Zhang, K.Q. (2020) Struc-ture, Regulation, and Function of Linear and Circular Long Non-Coding RNAs. Frontiers in Genetics, 11, Article No. 150. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Dutta, A., Roy, A. and Chatterjee, S. (2021) Long Noncoding RNAs in Cancer Immunity: A New Avenue in Drug Discovery. Drug Discovery Today, 26, 264-272. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Chen, T., Liu, R., Niu, Y., et al. (2021) HIF-1alpha-Activated Long Non-Coding RNA KDM4A-AS1 Promotes Hepatocellular Carcinoma Progression via the miR-411-5p/KPNA2/AKT Pathway. Cell Death & Disease, 12, Article No. 1152. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Paraskevopoulou, M.D. and Hatzigeorgiou, A.G. (2016) Ana-lyzing MiRNA-LncRNA Interactions. Methods in Molecular Biology, 1402, 271-286. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Abildgaard, C., Do, C.L., Steffensen, K.D., et al. (2019) Long Non-Coding RNAs Involved in Resistance to Chemotherapy in Ovarian Cancer. Frontiers in Oncology, 9, Article No. 1549. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
He, J., Yan, H., Wei, S., et al. (2021) LncRNA ST8SIA6-AS1 Promotes Cholangiocarcinoma Progression by Suppressing the miR-145-5p/MAL2 Axis. OncoTargets and Therapy, 14, 3209-3223. [Google Scholar] [CrossRef]
|
|
[8]
|
Liu, Y., Sharma, S. and Watabe, K. (2015) Roles of LncRNA in Breast Cancer. Frontiers in Bioscience (Scholar Edition), 7, 94-108. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Dimitrova, N., Zamudio, J.R., Jong, R.M., et al. (2014) LincRNA-p21 Activates p21 in Cis to Promote Polycomb Target Gene Expres-sion and to Enforce the G1/S Checkpoint. Molecular Cell, 54, 777-790. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Jeong, G., Bae, H., Jeong, D., et al. (2018) A Kelch Do-main-Containing KLHDC7B and a Long Non-Coding RNA ST8SIA6-AS1 Act Oppositely on Breast Cancer Cell Pro-liferation via the Interferon Signaling Pathway. Scientific Reports, 8, Article No. 12922. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Luo, M.L., Li, J., Shen, L., et al. (2020) The Role of APAL/ST8SIA6-AS1 LncRNA in PLK1 Activation and Mitotic Catastrophe of Tumor Cells. JNCI: Journal of the Na-tional Cancer Institute, 112, 356-368. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Chen, X., Yuan, Q., Liu, J., Xia, S., Shi, X., Su, Y., Wang, Z., Li, S. and Shang, D. (2022) Comprehensive Characterization of Extracellular Matrix-Related Genes in PAAD Identified a Novel Prognostic Panel Related to Clinical Outcomes and Immune Microenvironment: A Silico Analysis with in Vivo and Vitro Validation. Frontiers in Immunology, 13, Article ID: 985911. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Feng, T., Yao, Y., Luo, L., Zou, H., Xiang, G., Wei, L., Yang, Q., Shi, Y., Huang, X. and Lai, C. (2023) ST8SIA6-AS1 Contributes to Hepatocellular Carcinoma Progression by Tar-geting miR-142-3p/HMGA1 Axis. Scientific Reports, 13, Article No. 650. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Huang, C.M., Cao, G.Y., Yang, C.X., et al. (2020) LncRNA ST8SIA6-AS1 Promotes Colorectal Cancer Cell Proliferation, Migration and Invasion by Regulating the miR-5195/PCBP2 Axis. European Review for Medical and Pharmacological Sciences, 24, 4203-4211.
|
|
[15]
|
Zhang, Y., Yang, Y., Zhang, Y. and Liu, Z. (2021) LncRNA ST8SIA6-AS1 Facilitates Proliferation and Invasion in Liver Cancer by Re-Gulating miR-142-3p. Experimental and Therapeutic Medicine, 22, Article No. 1348. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Vousden, K.H. and Prives, C. (2009) Blinded by the Light: The Growing Complexity of p53. Cell, 137, 413-431. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Cao, Q., Yang, W., Ji, X., et al. (2020) Long Non-Coding RNA ST8SIA6-AS1 Promotes Lung Adenocarcinoma Progression through Sponging miR-125a-3p. Frontiers in Genetics, 11, Article ID: 597795. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
宋国全, 姜鹏, 李子华, 等. ST8SIA6-AS1对骨肉瘤细胞增殖和转移的影响及其分子机制[J]. 实用临床医药杂志, 2022, 26(8): 99-103.
|
|
[19]
|
Jin, Y., Feng, S.J., Qiu, S., et al. (2017) LncRNA MALAT1 Promotes Proliferation and Metastasis in Epithelial Ovarian Cancer via the PI3K-AKT Path-way. European Review for Medical and Pharmacological Sciences, 21, 3176-3184.
|
|
[20]
|
Xia, H., Liu, Y., Wang, Z., et al. (2020) Long Noncoding RNA HOTAIRM1 Maintains Tumorigenicity of Glioblastoma Stem-Like Cells through Regulation of HOX Gene Expression. Neurotherapeutics, 17, 754-764. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Basse, C. and Arock, M. (2015) The Increasing Roles of Epige-netics in Breast Cancer: Implications for Pathogenicity, Biomarkers, Prevention and Treatment. International Journal of Cancer, 137, 2785-2794. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Johnson, M.D., Woodburn, C.J. and Vance, M.L. (2003) Quality of Life in Patients with a Pituitary Adenoma. Pituitary, 6, 81-87. [Google Scholar] [CrossRef]
|
|
[23]
|
Ezzat, S., Asa, S.L., Couldwell, W.T., et al. (2004) The Prevalence of Pituitary Adenomas: A Systematic Review. Cancer, 101, 613-619. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Vierimaa, O., Georgitsi, M., Lehtonen, R., et al. (2006) Pituitary Adenoma Predisposition Caused by Germline Mutations in the AIP Gene. Science, 312, 1228-1230. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Li, Z., Zhang, C., Zong, X., et al. (2022) ST8SIA6-AS1 Promotes the Epithelial-to-Mesenchymal Transition and Angiogenesis of Pituitary Adenoma. Journal of Oncology, 2022, Article ID: 7960261.
|
|
[26]
|
(2021) Hepatocellular Carcinoma. Nature Reviews Disease Primers, 7, Article No. 7. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Akinyemiju, T., Abera, S., Ahmed, M., et al. (2017) The Burden of Primary Liver Cancer and Underlying Etiologies from 1990 to 2015 at the Global, Regional, and National Level: Re-sults from the Global Burden of Disease Study 2015. JAMA Oncology, 3, 1683-1691. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Bray, F., Ferlay, J., Soerjomataram, I., et al. (2018) Global Can-cer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Wang, L., Sun, L., Liu, R., et al. (2021) Long Non-Coding RNA MAPKAPK5-AS1/PLAGL2/HIF-1alpha Signaling Loop Promotes Hepatocellular Carcinoma Progression. Journal of Experimental & Clinical Cancer Research, 40, Article No. 72. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Kuai, J., Zheng, L., Yi, X., et al. (2021) ST8SIA6-AS1 Pro-motes the Development of Hepatocellular Carcinoma Cells through miR-338-3p/NONO Axis. Digestive and Liver Dis-ease, 53, 1192-1200. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Li, Y. and Jiang, A. (2020) ST8SIA6-AS1 Promotes Hepatocellular Carcinoma by Absorbing miR-5195-3p to Regulate HOXB6. Cancer Biology & Therapy, 21, 647-655. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Lorenzi, L., Aviln Cobos, F., Decock, A., et al. (2019) Long Noncoding RNA Expression Profiling in Cancer: Challenges and Opportunities. Genes Chromosomes Cancer, 58, 191-199. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Fei, Q., Song, F., Jiang, X., et al. (2020) LncRNA ST8SIA6-AS1 Promotes Hepatocellular Carcinoma Cell Proliferation and Resistance to Apoptosis by Targeting miR-4656/HDAC11 Axis. Cancer Cell International, 20, Article No. 232. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Guo, X., Zhang, Y., Zheng, L., et al. (2018) Global Characterization of T Cells in Non-Small-Cell Lung Cancer by Single-Cell Sequencing. Nature Medicine, 24, 978-985. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Barta, J.A., Powell, C.A. and Wisnivesky, J.P. (2019) Global Epidemiology of Lung Cancer. Annals of Global Health, 85, Article No. 8. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Nanavaty, P., Alvarez, M.S. and Alberts, W.M. (2014) Lung Cancer Screening: Advantages, Controversies, and Applications. Cancer Control, 21, 9-14. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Li, H., Zhao, M., Fei, G., et al. (2022) Epidemiological Trends and Incidence Prediction of Lung Cancer in China Based on the Global Burden of Disease Study 2019. Frontiers in Medicine (Lausanne), 9, Article ID: 969487. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Siegel, R.L., Miller, K.D. and Jemal, A. (2018) Cancer Statistics, 2018. CA: A Cancer Journal for Clinicians, 68, 7-30. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Zhang, H., Guo, L. and Chen, J. (2020) Rationale for Lung Adenocarci-noma Prevention and Drug Development Based on Molecular Biology During Carcinogenesis. OncoTargets and Thera-py, 13, 3085-3091. [Google Scholar] [CrossRef]
|
|
[40]
|
Dillman, R.O., Wiemann, M.C., Tai, D.F., Depriest, C.B., Soori, G., Stark, J.J., Mahdavi, K. and Church, C.K. (2006) Phase II Trial of Subcu-Taneous Interferon Followed by Intravenous Hybrid Bolus/Continuous Infusion Interleukin-2 in the Treatment of Renal Cell Carcinoma: Final Results of Cancer Bio-therapy Research Group 95-09. Cancer Biotherapy and Radiopharmaceuticals, 21, 130-137. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Giaquinto, A.N., Sung, H., Miller, K.D., et al. (2022) Breast Cancer Statistics, 2022. CA: A Cancer Journal for Clinicians, 72, 524-541. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Feng, Y., Spezia, M., Huang, S., et al. (2018) Breast Cancer Development and Progression: Risk Factors, Cancer Stem Cells, Signaling Pathways, Genomics, and Molecular Pathogenesis. Genes & Diseases, 5, 77-106. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Elia, R., Maruccia, M., De Pascale, A., et al. (2021) The Man-agement of Breast Implant-Associated Anaplastic Large Cell Lymphoma in the Setting of Pregnancy: Seeking for Clinical Practice Guidelines. Archives of Plastic Surgery, 48, 373-377. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Li, Z., Hou, P., Fan, D., et al. (2017) The Degradation of EZH2 Mediated by LncRNA ANCR Attenuated the Invasion and Metastasis of Breast Cancer. Cell Death & Differentiation, 24, 59-71. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Kopp, F. and Mendell, J.T. (2018) Functional Classification and Experi-mental Dissection of Long Noncoding RNAs. Cell, 172, 393-407. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Fang, K., Hu, C., Zhang, X., et al. (2020) LncRNA ST8SIA6-AS1 Promotes Proliferation, Migration and Invasion in Breast Cancer through the p38 MAPK Signalling Pathway. Carcino-genesis, 41, 1273-1281. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
Qiao, Y., Wang, B., Yan, Y., et al. (2022) Long Noncoding RNA ST8SIA6-AS1 Promotes Cell Proliferation and Metastasis in Triple-Negative Breast Cancer by Targeting miR-145-5p/CDCA3 to Inactivate the p53/p21 Signaling Pathway. Environmental Toxicology, 37, 2398-2411. [Google Scholar] [CrossRef] [PubMed]
|
|
[48]
|
Cardinale, V. (2019) Classifications and Misclassification in Cholangiocar-cinoma. Liver International, 39, 260-262. [Google Scholar] [CrossRef] [PubMed]
|
|
[49]
|
Siegel, R.L., Miller, K.D. and Jemal, A. (2019) Cancer Statistics, 2019. CA: A Cancer Journal for Clinicians, 69, 7-34. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Khan, S.A., Tavolari, S. and Brandi, G. (2019) Cholangiocarcinoma: Epi-demiology and Risk Factors. Liver International, 39, 19-31. [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Banales, J.M., Cardinale, V., Carpino, G., et al. (2016) Expert Consensus Document: Cholangiocarcinoma: Current Knowledge and Future Perspectives Consensus Statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). Nature Reviews Gastroenterology & Hepatology, 13, 261-280. [Google Scholar] [CrossRef] [PubMed]
|
|
[52]
|
Brindley, P.J., Bachini, M., Ilyas, S.I., et al. (2021) Cholangiocarci-noma. Nature Reviews Disease Primers, 7, Article No. 65. [Google Scholar] [CrossRef] [PubMed]
|
|
[53]
|
Siegel, R., Miller, K.D., Goding, S.A., et al. (2020) Colorectal Cancer Statistics, 2020. CA: A Cancer Journal for Clinicians, 70, 145-164. [Google Scholar] [CrossRef] [PubMed]
|
|
[54]
|
Dekker, E., Tanis, P.J., Vleugels, J., et al. (2019) Colorectal Cancer. The Lancet, 394, 1467-1480. [Google Scholar] [CrossRef]
|
|
[55]
|
Primrose, J., Falk, S., Finch-Jones, M., et al. (2014) Sys-temic Chemotherapy with or without Cetuximab in Patients with Resectable Colorectal Liver Metastasis: The New EPOC Randomised Controlled Trial. The Lancet Oncology, 15, 601-611. [Google Scholar] [CrossRef]
|
|
[56]
|
Thanindratarn, P., Dean, D.C., Nelson, S.D., et al. (2019) Advances in Immune Checkpoint Inhibitors for Bone Sarcoma Therapy. Journal of Bone Oncology, 15, Article ID: 100221. [Google Scholar] [CrossRef] [PubMed]
|
|
[57]
|
Mirabello, L., Troisi, R.J. and Savage, S.A. (2009) Osteo-sarcoma Incidence and Survival Rates from 1973 to 2004: Data from the Surveillance, Epidemiology, and End Results Program. Cancer, 115, 1531-1543. [Google Scholar] [CrossRef] [PubMed]
|
|
[58]
|
Ferrari, S., Mercuri, M. and Bacci, G. (2002) Comment on “Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols”. Journal of Clinical Oncology, 20, 2910-2911. [Google Scholar] [CrossRef]
|
|
[59]
|
Zhang, X., Xu, S., Hu, C., et al. (2020) LncRNA ST8SIA6-AS1 Promotes Hepatocellular Carcinoma Progression by Regulating MAGEA3 and DCAF4L2 Expression. Biochemical and Biophysical Research Communications, 533, 1039-1047. [Google Scholar] [CrossRef] [PubMed]
|